Pebblebrook Hotel Trust heads into its April 29 Q1 earnings call carrying one of the heavier short positions in the hotel REIT universe, even as the stock has staged a sharp recovery over the past month.
Short sellers remain meaningfully committed to the downside. At 14% of free float, short interest is running well above what most hotel REIT peers carry, and it has crept higher over the past week — up nearly 2% — after declining through most of April. The ORTEX short score of 63.5 ranks in the bottom 4th percentile of the broader market, marking this as a stock where bearish positioning is genuinely concentrated. Days to cover sits at 6.7 on official FINRA data, meaning any sharp move upward would take bears more than a week to exit at average volumes. The borrow market itself, however, tells a looser story: availability is ample and cost to borrow has eased to 0.48% — down 14% on the week — suggesting the short base is comfortable and not under immediate pressure to unwind.
The street is divided, and that division sharpens the setup. The bull case rests on NAV recovery in San Francisco, better-than-expected EBITDA from legacy properties, and management's claimed market share gains. Evercore ISI lifted its target to $15 on April 27 — the day before earnings — while holding an In-Line rating, a signal of cautious optimism. Morgan Stanley kept its Underweight but nudged its target to $10 from $9 earlier this month, and Barclays holds a matching $9 Underweight. That split — one cluster of targets near or above the current $14.11 price, another anchored well below it — captures the bear case directly: heavy urban market concentration in Boston, Los Angeles, San Francisco, and South Florida, where international travel demand has not recovered, combined with doubt that major capex programs will translate into incremental EBITDA gains on any near-term horizon. The mean analyst price target of $13.57 sits fractionally below the current price, underscoring just how contested the valuation is.
The options market reflects modest but real caution. The put/call ratio nudged up to 1.30 on April 28, a tick above its 20-day average of 1.24. That's not an extreme reading — far from the 52-week high of 4.62 — but the direction of travel into the print is slightly more defensive. Meanwhile the stock itself has rallied 15% over the past month to $14.11, outperforming most close peers on the week: RLJ fell 2.2%, PK dropped 3%, and DRH lost 2.7%, while PEB held its ground with a 1.3% weekly gain. That relative strength into the print adds to the pressure on the numbers.
The Q1 report is therefore less a test of whether Pebblebrook is recovering and more a question of whether urban RevPAR trends and margin performance can justify a stock that has already repriced sharply higher — while 14% of the float remains positioned for it to fall back.
See the live data behind this article on ORTEX.
Open PEB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
